Cargando…
Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review
Novel SARS-CoV-2 (COVID-19) is affecting worldwide as declared pandemic by the WHO. Various repositioning and novel therapeutic agents are being evaluated under different clinical setups; however, there is no promising therapeutic agent reported to date. Small molecules like peptides have their popu...
Autores principales: | Kumaravel, J., Singh, Harvinder, Kaur, Sukhmeet, Prakash, Ajay, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204890/ https://www.ncbi.nlm.nih.gov/pubmed/36960521 http://dx.doi.org/10.4103/ijp.ijp_700_22 |
Ejemplares similares
-
Update on omicron variant: What we know so far
por: Choudhary, Gajendra, et al.
Publicado: (2022) -
Artificial intelligence in pharmacovigilance: Practical utility
por: Murali, Kotni, et al.
Publicado: (2019) -
Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: An experimental exploratory study
por: Prakash, Ajay, et al.
Publicado: (2013) -
Effect of esomeprazole on the pharmacokinetics of carbamazepine
por: Medhi, Bikash, et al.
Publicado: (2011) -
Paxlovid: A promising drug for the challenging treatment of SARS-COV-2 in the pandemic era
por: Niraj, Niraj, et al.
Publicado: (2022)